Important information relating to Supply of Muse (Alprostadil) Urethral Sticks

To ensure on-going market availability of MUSE urethral sticks in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) have granted a batch specific variation to enable supply of packs with a defective anti-tamper seal.

Direct Healthcare Professional Communication

Click here to download letter sent to Healthcare Professionals

Mylan is unable to make any specific treatment recommendations to patients and recommend that patients speak to their healthcare provider to discuss treatment options according to their own health needs and their relevant clinical history.

Reporting Adverse Reactions/Events

Please continue to report suspected adverse reactions with any medicine or vaccine to the MHRA through the Yellow Card Scheme.

It is easiest and quickest to report ADRs online via the Yellow Card website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Alternatively, you can report via some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank) or by calling the Commission on Human Medicines (CHM) free phone line: 0800-731-6789.

Adverse reactions/events should also be reported to MAH at e-mail address: ukpharmacovigilance@mylan.com.

About Muse

Muse^® is indicated for the treatment of erectile dysfunction of primarily organic etiology.

Resources

MUSE^® urethral stick (alprostadil)

MUSE^® 500mg SmPC
MUSE^® 500mg Patient Information Leaflet

MUSE^® 1000mg SmPC
MUSE^® 1000mg Patient Information Leaflet

Contact Information

Mylan Medical Information team can be contacted via the Mylan switch board on 01707 853000

DOP: October 2020
MUS-2020-0004